• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用酰胺质子转移加权磁共振成像对子宫内膜样腺癌中错配修复缺陷型和错配修复 proficient 型肿瘤进行无创鉴别。 (注:原文中“proficient”直接翻译过来是“精通的、熟练的”等意思,在这里结合语境,可能是想说“错配修复功能完整型”,可根据实际情况进一步确认准确表述并完善译文)

Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma.

作者信息

Li Yuan, Liu Xinyu, Wang Xiaoqi, Lin Chengyu, Qi Yafei, Chen Bo, Zhou Hailong, Wu Qiaoling, Ren Jing, Zhao Jia, Yang Junjun, Xiang Yang, He Yonglan, Jin Zhengyu, Xue Huadan

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, People's Republic of China.

Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Shuai Fu Yuan 1#, Dongcheng Dist., Beijing, 100730, People's Republic of China.

出版信息

Insights Imaging. 2021 Dec 11;12(1):182. doi: 10.1186/s13244-021-01126-y.

DOI:10.1186/s13244-021-01126-y
PMID:34894294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8665952/
Abstract

OBJECTIVES

To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA).

METHODS

Forty-nine patients with EEA underwent T1-weighted imaging, T2-weighted imaging, 3D APTw imaging, and diffusion-weighted imaging at 3 T MRI. Image quality and measurement confidence of APTw images were evaluated on a 5-point Likert scale. APTw and apparent diffusion coefficient (ADC) values were calculated and compared between the dMMR and pMMR groups and among the three EEA histologic grades based on the Federation of Gynecology and Obstetrics (FIGO) grading system criteria. Student's t-test, analysis of variance with Scheffe post hoc test, and receiver operating characteristic analysis were performed. Statistical significance was set at p < 0.05.

RESULTS

Thirty-five EEA patients (9 with dMMR tumors and 26 with pMMR tumors) with good image quality were enrolled in quantitative analysis. APTw values were significantly higher in the dMMR group than in the pMMR group (3.2 ± 0.3% and 2.8 ± 0.5%, respectively; p = 0.019). ADC values of the dMMR and pMMR groups were 0.874 ± 0.104 × 10 mm/s and 0.903 ± 0.100 × 10 mm/s, respectively. No significant between-group difference was noted (p = 0.476). No statistically significant differences were observed in APTw values or ADC values among the three histologic grades (p = 0.766 and p = 0.295, respectively).

CONCLUSIONS

APTw values may be used as potential imaging markers to differentiate dMMR from pMMR tumors in EEA.

摘要

目的

探讨三维(3D)酰胺质子转移加权(APTw)成像在鉴别子宫内膜样腺癌(EEA)中错配修复缺陷(dMMR)和错配修复 proficient(pMMR)肿瘤中的应用价值。

方法

49例EEA患者在3T磁共振成像(MRI)上接受了T1加权成像、T2加权成像、3D APTw成像和扩散加权成像。APTw图像的图像质量和测量置信度采用5分制Likert量表进行评估。根据妇科肿瘤联合会(FIGO)分级系统标准,计算并比较dMMR组和pMMR组以及三种EEA组织学分级之间的APTw和表观扩散系数(ADC)值。进行了学生t检验、Scheffe事后检验的方差分析和受试者操作特征分析。统计学显著性设定为p < 0.05。

结果

35例图像质量良好的EEA患者(9例dMMR肿瘤患者和26例pMMR肿瘤患者)纳入定量分析。dMMR组的APTw值显著高于pMMR组(分别为3.2±0.3%和2.8±0.5%;p = 0.019)。dMMR组和pMMR组的ADC值分别为0.874±0.104×10 mm/s和0.903±0.100×10 mm/s。组间差异无统计学意义(p = 0.476)。三种组织学分级之间的APTw值或ADC值均未观察到统计学显著差异(分别为p = 0.766和p = 0.295)。

结论

APTw值可作为鉴别EEA中dMMR和pMMR肿瘤的潜在成像标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/d1ddce37ee2f/13244_2021_1126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/da7d1accb581/13244_2021_1126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/a86b96c1727d/13244_2021_1126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/694a7b81b072/13244_2021_1126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/71a3331305a7/13244_2021_1126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/d1ddce37ee2f/13244_2021_1126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/da7d1accb581/13244_2021_1126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/a86b96c1727d/13244_2021_1126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/694a7b81b072/13244_2021_1126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/71a3331305a7/13244_2021_1126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306b/8665952/d1ddce37ee2f/13244_2021_1126_Fig5_HTML.jpg

相似文献

1
Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma.使用酰胺质子转移加权磁共振成像对子宫内膜样腺癌中错配修复缺陷型和错配修复 proficient 型肿瘤进行无创鉴别。 (注:原文中“proficient”直接翻译过来是“精通的、熟练的”等意思,在这里结合语境,可能是想说“错配修复功能完整型”,可根据实际情况进一步确认准确表述并完善译文)
Insights Imaging. 2021 Dec 11;12(1):182. doi: 10.1186/s13244-021-01126-y.
2
Prediction of Kirsten rat sarcoma () mutation in rectal cancer with amide proton transfer-weighted magnetic resonance imaging.利用酰胺质子转移加权磁共振成像预测直肠癌中的 Kirsten 大鼠肉瘤()突变
Quant Imaging Med Surg. 2024 Oct 1;14(10):7061-7072. doi: 10.21037/qims-24-331. Epub 2024 Sep 4.
3
Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.直肠腺癌的三维酰胺质子转移 MRI:与病理预后因素的相关性及与扩散峰度成像的比较
Eur Radiol. 2021 May;31(5):3286-3296. doi: 10.1007/s00330-020-07397-1. Epub 2020 Oct 30.
4
Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI.酰胺质子转移加权磁共振成像在子宫良性病变与子宫内膜腺癌的无创鉴别诊断中的应用
Mol Imaging Biol. 2021 Jun;23(3):446-455. doi: 10.1007/s11307-020-01565-x. Epub 2020 Nov 13.
5
Amide proton transfer-weighted MRI for predicting histological grade of hepatocellular carcinoma: comparison with diffusion-weighted imaging.酰胺质子转移加权磁共振成像预测肝细胞癌组织学分级:与扩散加权成像的比较
Quant Imaging Med Surg. 2019 Oct;9(10):1641-1651. doi: 10.21037/qims.2019.08.07.
6
Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.酰胺质子转移加权磁共振成像在肾肿瘤中的应用:与弥散加权成像的比较。
Magn Reson Imaging. 2024 Feb;106:104-109. doi: 10.1016/j.mri.2023.12.002. Epub 2023 Dec 21.
7
Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.酰胺质子转移加权磁共振成像和扩散加权成像在膀胱癌中的应用:VI-RADS 的补充工具。
Acad Radiol. 2024 Feb;31(2):564-571. doi: 10.1016/j.acra.2023.09.005. Epub 2023 Oct 10.
8
Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.酰胺质子转移(APT)和磁化转移(MT)在预测鼻咽癌放化疗后短期疗效中的作用:三维化学交换饱和传递(CEST)MRI 的可行性研究。
Cancer Imaging. 2023 Sep 1;23(1):80. doi: 10.1186/s40644-023-00602-6.
9
Image quality assessment and feasibility of three-dimensional amide proton transfer-weighted imaging for hepatocellular carcinoma.肝细胞癌三维酰胺质子转移加权成像的图像质量评估及可行性
Quant Imaging Med Surg. 2024 Feb 1;14(2):1778-1790. doi: 10.21037/qims-23-767. Epub 2024 Jan 23.
10
Early prediction of pathological response to neoadjuvant chemotherapy of breast tumors: a comparative study using amide proton transfer-weighted, diffusion weighted and dynamic contrast enhanced MRI.乳腺肿瘤新辅助化疗病理反应的早期预测:一项使用酰胺质子转移加权、扩散加权和动态对比增强磁共振成像的对比研究
Front Med (Lausanne). 2024 Jan 17;11:1295478. doi: 10.3389/fmed.2024.1295478. eCollection 2024.

引用本文的文献

1
Accuracy and Reliability of Synthetic Computed Tomography for Model-Based Tracking of Biplane Videoradiography Data.基于模型的双平面视频放射成像数据跟踪中合成计算机断层扫描的准确性和可靠性
Ann Biomed Eng. 2025 Aug 23. doi: 10.1007/s10439-025-03831-x.
2
Co-reactivity pattern of glucose metabolism and blood perfusion revealing DNA mismatch repair deficiency based on PET/DCE-MRI in endometrial cancer.基于 PET/DCE-MRI 的子宫内膜癌葡萄糖代谢与血供的共反应性模式揭示 DNA 错配修复缺陷。
Cancer Imaging. 2024 Nov 25;24(1):161. doi: 10.1186/s40644-024-00805-5.
3
Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective study.

本文引用的文献

1
Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.肝脏的扩散加权磁共振成像:表观扩散系数和体素内不相干运动定量的挑战与一些解决方案
Am J Nucl Med Mol Imaging. 2021 Apr 15;11(2):107-142. eCollection 2021.
2
Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging Facilitates Preoperative Risk Stratification of Early-Stage Endometrial Carcinoma.酰胺质子转移加权成像和多种模型弥散加权成像有助于术前对早期子宫内膜癌进行风险分层。
J Magn Reson Imaging. 2021 Oct;54(4):1200-1211. doi: 10.1002/jmri.27684. Epub 2021 May 15.
3
基于亚区域的酰胺质子转移加权磁共振成像直方图分析预测直肠腺癌肿瘤芽生分级的前瞻性研究
Eur Radiol. 2025 Mar;35(3):1382-1393. doi: 10.1007/s00330-024-11172-x. Epub 2024 Nov 5.
4
Multimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer.多模态磁共振成像用于评估子宫内膜癌中的Her-2基因表达
Bioengineering (Basel). 2023 Dec 6;10(12):1399. doi: 10.3390/bioengineering10121399.
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
ESGO/ESTRO/ESP 指南:子宫内膜癌患者管理
Radiother Oncol. 2021 Jan;154:327-353. doi: 10.1016/j.radonc.2020.11.018.
4
Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma: Correlation with Ki-67 proliferation status.三维涡轮自旋回波酰胺质子转移加权成像和体素内不相干运动磁共振成像在I型子宫内膜癌中的应用:与Ki-67增殖状态的相关性
Magn Reson Imaging. 2021 May;78:18-24. doi: 10.1016/j.mri.2021.02.006. Epub 2021 Feb 6.
5
Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI.酰胺质子转移加权磁共振成像在子宫良性病变与子宫内膜腺癌的无创鉴别诊断中的应用
Mol Imaging Biol. 2021 Jun;23(3):446-455. doi: 10.1007/s11307-020-01565-x. Epub 2020 Nov 13.
6
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
7
Incorporation of molecular characteristics into endometrial cancer management.将分子特征纳入子宫内膜癌的管理中。
Histopathology. 2020 Jan;76(1):52-63. doi: 10.1111/his.14015.
8
Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.子宫内膜癌中的错配修复缺陷:免疫组织化学染色及临床意义
Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):678-682. doi: 10.1097/PAI.0000000000000641.
9
A novel normalization for amide proton transfer CEST MRI to correct for fat signal-induced artifacts: application to human breast cancer imaging.一种新的酰胺质子转移 CEST MRI 归一化方法,用于校正脂肪信号引起的伪影:在人类乳腺癌成像中的应用。
Magn Reson Med. 2020 Mar;83(3):920-934. doi: 10.1002/mrm.27983. Epub 2019 Sep 18.
10
Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study.三维涡轮自旋回波酰胺质子转移加权磁共振成像在宫颈癌中的初步研究。
J Magn Reson Imaging. 2019 Oct;50(4):1318-1325. doi: 10.1002/jmri.26710. Epub 2019 Mar 12.